Related Experiment Video
Updated: Jul 11, 2026
04:24
Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
Published on: September 5, 2025
Adaptive treatment strategies in chronic disease
1Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California 94305-5405, USA. lavori@stanford.edu
Annual Review of Medicine
|October 5, 2007
Summary
Adaptive treatment strategies (ATS) dynamically adjust patient care based on early response markers. Sequential multiple assignment randomized trials can optimize and compare these strategies for better chronic disease management.
Area of Science:
- * Clinical trial design
- * Biostatistics
- * Chronic disease management
Background:
- * Adaptive treatment strategies (ATS) guide treatment adjustments based on patient history and response.
- * ATS can be implicit or explicit, aiming for favorable long-term outcomes using early response indicators.
- * Dynamic alteration of treatment decisions is key to effective ATS.
Purpose of the Study:
- * To illustrate the concept of adaptive treatment strategies (ATS).
- * To demonstrate how initial treatment decisions impact later stages.
- * To present methods for comparing and optimizing ATS using sequential multiple assignment randomized (SMAR) trials.
Main Methods:
- * Conceptual illustration of ATS.
- * Analysis of decision-making dependencies in sequential treatment.
- * Application of sequential multiple assignment randomized (SMAR) trials for ATS evaluation.
Main Results:
- * The performance of subsequent treatment decisions significantly influences the effectiveness of initial choices.
- * SMAR trials provide a framework for comparing multiple ATS.
- * SMAR trials can identify optimal adaptive treatment strategies.
Conclusions:
- * ATS offer a dynamic approach to chronic disease management.
- * SMAR trials enhance the efficiency and ecological relevance of clinical research.
- * The ATS framework can improve clinical trial design and patient outcomes.
Related Concept Videos
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:18Chronic Kidney Disease IV: Nursing Management
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...